News

Over the last six months, Brookdale’s shares have sunk to $5.81, producing a disappointing 15.9% loss - a stark contrast to the S&P 500’s 5.2% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.

Pediatrix Medical Group has been on fire lately. In the past six months alone, the company’s stock price has rocketed 51.5%, reaching $16 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

What a brutal six months it’s been for Illumina. The stock has dropped 30.9% and now trades at $84.65, rattling many shareholders. This may have investors wondering how to approach the situation.

Charter’s 17.9% return over the past six months has outpaced the S&P 500 by 12.8%, and its stock price has climbed to $383.08 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Evolent Health has gotten torched over the last six months - since September 2024, its stock price has dropped 71.1% to $8.76 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.

Solana’s decentralized exchange (DEX) volumes remain competitive with Ethereum’s ecosystem despite a sharp decline in meme coin trading activity.

Atos said on Friday it is launching a reverse stock split as the French IT group aims to restore investor confidence after completing a financial restructuring plan last year to overcome a crushing debt crisis. The stock split will start on March 25 and will end on April 23, Atos said in a statement. Atos' shares are trading at all-time lows, to about half of a cent, after the company completed a 233-million-euro capital increase last year, causing massive dilution for shareholders.